Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas C Shea

Showing results (1-10 of 80) with videos related to

Pageof 8
Sort By:
Drugs of Today (Barcelona, Spain : 1998)|August 31, 2007
Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplantAnne W Beaven, Thomas C Shea
Expert Opinion on Pharmacotherapy|October 25, 2006
Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignanciesAnne W Beaven, Thomas C Shea
North Carolina Medical Journal|October 7, 2024
"Success is dependent on prevention and early detection" - A Conversation with Oncologist and Researcher Dr. Thomas C. SheaPeter J Morris, Thomas C Shea
Supportive Cancer Therapy|July 18, 2008
The effect of palifermin on chemotherapyand radiation therapy-induced mucositis: a review of the current literatureAnne W Beaven, Thomas C Shea
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2012
Controversies in BMT for lymphomaRandy D Gascoyne, Craig Moskowitz, Thomas C Shea
The Journal of Molecular Diagnostics : JMD|December 5, 2009
Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemiaMargaret L Gulley, Thomas C Shea, Yuri Fedoriw
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 12, 2019
Successful treatment of hepatitis C virus infection with direct-acting antivirals during hematopoietic cell transplantHayley E Cunningham, Thomas C Shea, Tatjana Grgic, et al.
Nuclear Medicine Communications|June 19, 2009
Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomographyAmir H Khandani, Cherie H Dunphy, Patcharica Meteesatien, et al.
Leukemia & Lymphoma|April 11, 2017
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohortDamon E Houghton, Nigel S Key, Neil A Zakai, et al.
Cancer Investigation|February 15, 2011
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myelomaAnne W Beaven, Dominic T Moore, Andrew Sharf, et al.
Pageof 8

Showing results (1-10 of 80) with videos related to

Sort By:
Pageof 8
Drugs of Today (Barcelona, Spain : 1998)|August 31, 2007
Recombinant human keratinocyte growth factor palifermin reduces oral mucositis and improves patient outcomes after stem cell transplantAnne W Beaven, Thomas C Shea
Expert Opinion on Pharmacotherapy|October 25, 2006
Palifermin: a keratinocyte growth factor that reduces oral mucositis after stem cell transplant for haematological malignanciesAnne W Beaven, Thomas C Shea
North Carolina Medical Journal|October 7, 2024
"Success is dependent on prevention and early detection" - A Conversation with Oncologist and Researcher Dr. Thomas C. SheaPeter J Morris, Thomas C Shea
Supportive Cancer Therapy|July 18, 2008
The effect of palifermin on chemotherapyand radiation therapy-induced mucositis: a review of the current literatureAnne W Beaven, Thomas C Shea
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|October 24, 2012
Controversies in BMT for lymphomaRandy D Gascoyne, Craig Moskowitz, Thomas C Shea
The Journal of Molecular Diagnostics : JMD|December 5, 2009
Genetic tests to evaluate prognosis and predict therapeutic response in acute myeloid leukemiaMargaret L Gulley, Thomas C Shea, Yuri Fedoriw
Transplant Infectious Disease : an Official Journal of the Transplantation Society|April 12, 2019
Successful treatment of hepatitis C virus infection with direct-acting antivirals during hematopoietic cell transplantHayley E Cunningham, Thomas C Shea, Tatjana Grgic, et al.
Nuclear Medicine Communications|June 19, 2009
Glut1 and Glut3 expression in lymphoma and their association with tumor intensity on 18F-fluorodeoxyglucose positron emission tomographyAmir H Khandani, Cherie H Dunphy, Patcharica Meteesatien, et al.
Leukemia & Lymphoma|April 11, 2017
Analysis of anticoagulation strategies for venous thromboembolism during severe thrombocytopenia in patients with hematologic malignancies: a retrospective cohortDamon E Houghton, Nigel S Key, Neil A Zakai, et al.
Cancer Investigation|February 15, 2011
Infusional mitoxantrone plus bolus melphalan as a stem cell transplant conditioning regimen for multiple myelomaAnne W Beaven, Dominic T Moore, Andrew Sharf, et al.
Pageof 8